Skip to Content
ON
DEMAND
Subscribe Now
News
Series
Conferences
Insights
Features
MORE
FORTUNE.COM
FORTUNE LIVE MEDIA
FORTUNE CONNECT
FORTUNE EDUCATION
FORTUNE WELL
FORTUNE CRYPTO
FORTUNE RECOMMENDS
Search
SIGN IN
Subscribe Now
Loading Video...
Series
Why GlaxoSmithKline Won't Do A Merger
December 08, 2015 17:54 PM UTC
- Updated January 31, 2020 12:47 PM UTC
CEO Andrew Witty explains to Fortune's Susie Gharib.
Sections
Leadership
Tags
Merger
On Leading
Leadership
Andrew Witty
GSK
GlaxoSmithKline
Pfizer
Allergan